Transdermal skin patches are adhesive patches that are placed on the skin to deliver medications through the skin and into the bloodstream. They offer multiple advantages over traditional oral medications such as convenience, improved efficacy, avoidance of intestinal hepatic first-pass metabolism, sustained drug delivery for improved patient compliance and safety. The increasing prevalence of chronic diseases such as diabetes, cancer pain, arthritis, neurological disorders which require long term treatment and management is driving the demand for transdermal drug patches for easy and controlled delivery of medications.
The global transdermal skin patches market size is estimated to be valued at US$ 8.79 billion in 2024 and is expected to exhibit a CAGR of 5.5% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the transdermal skin patches market are Novartis AG, Purdue
Pharma L.P., Viatris, Inc., Teikoku Pharma USA, Inc., Johnson and JohnsonServices, Inc.,
Teva Pharmaceutical Industries Ltd., LUYE PHARMA AG, Samyang Holdings Corporation,
Vektor Pharma, Hisamitsu Pharmaceutical Co.,Inc., UCB S.A., Hikma Pharmaceuticals PLC, Corium, Inc., Nitto Denko Corporation, Gedeon Richter Plc., Agile Therapeutics, Amneal Pharmaceuticals LLC., Cipla, and AdhexPharma.
The growing demand for self-administered and painless drug delivery drives the Transdermal Skin Patches Market share sustained and controlled drug release without causing gastric irritation, thus improving patient compliance. Further, companies are focusing on geographic expansion and product portfolio diversification through mergers, acquisitions and partnerships to strengthen their presence in global markets.
The key drivers propelling the transdermal skin patches market growth include the rising geriatric population and increasing prevalence of chronic diseases worldwide. As per WHO statistics, chronic diseases are estimated to account for 60% of all deaths globally. The growing need for convenient, continuous and controlled drug delivery methods for management of chronic conditions is a major market driver.
The key restraints affecting the market are stringent regulations associated with the approval of new transdermal patch products and technologies. Further, the high costs associated with R&D and clinical trials for patch delivery systems also hinder wider commercialization and adoption of novel products.
Market drivers:
1. Rising prevalence of chronic diseases worldwide requiring long term treatment
2. Growing geriatric population more prone to chronic illnesses
Market Restraints:
1. Stringent regulatory environment for approval of new patch products and technologies
2. High costs associated with R&D and clinical trials of patch delivery systems
Segment Analysis
The transdermal skin patches market is dominated by the pain management segment, which accounts for over 40% share. Transdermal patches have become an effective mode of administration for pain relief as they help in the sustained release of drugs through the skin and into the systemic circulation. The increasing incidence of chronic diseases like arthritis and musculoskeletal conditions is driving the demand for pain management patches.
The nicotine replacement therapy segment is another major segment in this market. Nicotine patches help in smoking cessation and account for over 30% of the market share. Stringent regulations and awareness programs regarding the risks of smoking have encouraged many smokers to opt for nicotine replacement therapies like patches.
Global Analysis
The North American region currently dominates the transdermal skin patches market with the largest share of over 40%, due to the rising prevalence of chronic diseases and a wellestablished healthcare system. However, the Asia Pacific region is expected to see the fastest growth during the forecast period owing to the improving access to healthcare in developing countries and the increasing adoption of modern treatment methods.
There is a growing demand for skin patches in China, India, and other Southeast Asian countries due to their rising geriatric population, increasing healthcare expenditures, and the introduction of innovative products. The expanding pharmaceutical industry in Asia is also contributing to market growth through increased production of generic patches. Regions like Latin America and the Middle East & Africa also present lucrative opportunities for market players.
Get More Insights On Transdermal Skin Patches Market
Get this Report in Japanese Language
Get this Reports in Korean Language
About Author:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )